Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 1103-1111

  Vouret Craviari, V ^a   Grall, D ^a   Van Obberghen Schilling, E ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Endothelial cells; Protease activated receptors; Rho

Indexed keywords

EID: 1842494553     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00238.x     Document Type: Article

References (51)

1. O'Brien PJ, Molino M, Kahn M, Brass LF. Protease activated receptors: theme and variations. Oncogene 2001; 20: 1570-81.
2. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-307.
3. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Proteaseactivated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001; 22: 146-52.
4. Griffin CT, Srinivasan Y, Zheng YW, Huang W, Coughlin SR. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 2001; 293: 1666-70.
5. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 2000; 279: L419-22.
6. Johnson A, Tahamont MV, Malik AB. Thrombin-induced lung vascular injury. Roles of fibrinogen and fibrinolysis. Am Rev Respir Dis 1983; 128: 38-44.
7. Lo SK, Perlman MB, Niehaus GD, Malik AB. Thrombin-induced alterations in lung fluid balance in awake sheep. J Appl Physiol 1985; 58: 1421-7.
8. Garcia JG, Verin AD, Schaphorst KL. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost 1996; 22: 309-15.
9. Hippenstiel S, Tannert OS, Vollrath N, Krull M, Just I, Aktories K, von Eichel-Streiber C, Suttorp N. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol 1997; 272: L38-L43.
10. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 1998; 273: 21867-74.
11. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van HinsberghVW. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 1998; 83: 1115-23.
12. Vouret-Craviari V, Boquet P, Pouyssegur J, Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 1998; 9: 2639-53.
13. Carbajal JM, Schaeffer RC Jr. RhoA inactivation enhances endothelial barrier function. Am J Physiol 1999; 277: C955-64.
14. Blackhart BD, Emilsson K, Nguyen D, TengW, Martelli AJ, Nystedt S, Sundelin J, Scarborough RM. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 1996; 271: 16466-71.
15. Mirza H, Yatsula V, Bahou WF. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest 1996; 97: 1705-14.
16. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 1996; 271: 14910-5.
17. Molino M, Woolkalis MJ, Reavey-Cantwell J, Pratico D, Andrade-Gordon P, Barnathan ES, Brass LF. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment J Biol Chem 1997; 272: 11133-41.
18. Cocks TM, Moffatt JD. Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 2000; 21: 103-8.
19. Kawabata A, Kuroda R, Minami T, Kataoka K, Taneda M. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br J Pharmacol 1998; 125: 419-22.
20. Vergnolle N, Hollenberg MD, Sharkey KA,Wallace JL. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 1999; 127: 1083-90.
21. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism Nat Med 2000; 6: 151-8.
22. Kawabata A, Saifeddine M, Al-Ani B, Hollenberg MD. Proteaseactivated receptors: development of agonists selective for receptors triggered by either thrombin (PAR1) or trypsin (Par2). Proc West Pharmacol Soc 1997; 40: 49-51.
23. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994; 91: 9208-12.
24. Barbieri B, Balconi G, Dejana B, Donati MB. Evidence that vascular endothelial cells can induce the retraction of fibrin clot. Proc Soc Exp Biol Med 1981; 168: 204-7.
25. Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, Bazalakova M, Neve RL, Corfas G, Debant A, Greenberg ME. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001; 105: 233-44.
26. Vouret-Craviari V, Bourcier C, Boulter E, Van Obberghen-Schilling E. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J Cell Sci 2002; 115: 2475-84.
27. Miles AA,Miles EF. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea pigs. J Physiol 1952; 118: 228-57.
28. Eliceiri BP, Cheresh DA. The role of alpha integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227-30.
29. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348: 241-55.
30. Ridley AJ. Rho family proteins: coordinating cell responses. Trends Cell Biol 2001; 11: 471-7.
31. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTPbinding protein Rho by cell adhesion and the cytoskeleton. EMBO J 1999; 18: 578-85.
32. Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA. Identification of a mouse p21Cdc42/Rac activated kinase. J Biol Chem 1995; 270: 22731-7.
33. Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA, Parsons JT. Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol 2000; 151: 29-40.
34. Symons M. Adhesion signaling: PAK meets Rac on solid ground. Curr Biol 2000; 10: R535-7.
35. Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002; 16: 1587-609.
36. Donovan S, Shannon KM, Bollag G. GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta 2002; 1602: 23-45.
37. Majumdar M, Seasholtz TM, Buckmaster C, Toksoz D, Brown JH. A rho exchange factor mediates thrombin and Galpha (12)-induced cytoskeletal responses. J Biol Chem 1999; 274: 26815-21.
38. Fukuhara S, Chikumi H, Gutkind JS. RGS-containing RhoGEFs. the missing link between transforming G proteins and Rho? Oncogene 2001; 20: 1661-8.
39. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PC. p115 RhoGEF, a GTPase activating protein for Galpha12 Galpha13. Science 1998; 280: 2109-11.
40. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G. Direct stimulation of the guanine nucleotide exchange activity of P115 Rhogef by Galpha13. Science 1998; 280: 2112-4.
41. Chikumi H, Fukuhara S, Gutkind JS. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase. J Biol Chem 2002; 277: 12463-73.
42. Langer F, Morys-Wortmann C, Kusters B, Storck J. Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release. Br J Haematol 1999; 105: 542-50.
43. Azim AC, Barkalow K, Chou J, Hartwig JH. Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 2000; 95: 959-64.
44. Uruno T, Liu J, Zhang P, Fan Y, Egile C, Li R, Mueller SC, Zhan X. Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol 2001; 3: 259-66.
45. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT, Cooper JA. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 2001; 11: 370-4.
46. Gumienny TL, Brugnera E, Tosello-Trampont AC, Kinchen JM, Haney LB, Nishiwaki K, Walk SF, Nemergut ME, Macara IG, Francis R, Schedl T, Qin Y, Van Aelst L, Hengartner MO, Ravichandran KS. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001; 107: 27-41.
47. Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S, Seiberg M. The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 2000; 113: 3093-101.
48. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. PG - 915-24. Mol Cell 1999; 4: 915-24.
49. Gasmi A, Bourcier C, Aloui Z, Srairi N, Marchetti S, Gimond C,Wedge SR, Hennequin L, Pouyssegur J. Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. ICPP is angiogenic via vascular endothelial growth factor receptor signalling J Biol Chem 2002; 277: 29992-8.
50. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001; 108: 689-701.
51. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 2001; 89: 92-8.